Filter
193
Filtered Results: 193
Text search:
tumour
markers
Featured
Recommendations
34
New Publications
42
Language
Document type
No document type
110
Guidelines
44
Studies & Reports
15
Manuals
12
Training Material
3
Fact sheets
3
Brochures
2
Strategic & Response Plan
2
App
1
Resource Platforms
1
Countries / Regions
India
32
Kenya
13
Nigeria
9
Global
8
South Africa
8
Ethiopia
4
Ghana
3
South–East Asia Region
3
Indonesia
3
Zimbabwe
2
Africa
2
Tanzania
2
West and Central Africa
2
Western and Central Europe
2
Eastern Europe
2
Timor Leste/ East Timor
1
Albania
1
Senegal
1
Malawi
1
Philippines
1
Eastern Europe and Central Asia
1
Bangladesh
1
Vietnam
1
Uganda
1
Georgia
1
Myanmar / Burma
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
80
Clinical Guidelines
51
Public Health
16
Women & Child Health
11
Capacity Building
4
Pharmacy & Technologies
4
Key Resources
1
Toolboxes
Mental Health
13
TB
13
HIV
12
Caregiver
7
NCDs
7
COVID-19
5
Pharmacy
5
NTDs
5
Disability
4
Ebola
3
Rapid Response
2
Planetary Health
2
Specific Hazards
1
Refugee
1
Conflict
1
4th Edition 2018
National Malaria Elimination & Aedes Transmitted Disease Control Program
Disease Control Unit Directorate General of Health Services
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
As part of our commitment to the fight against NCDs, Nigeria was signatory to the political declaration at the UN General Assembly High Level Meeting on NCDs in September 2011. Thus, the purpose of this document is to develop and ensure the implementation of policies and p...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem...
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
WHO Technical Series 971
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
